(Total Views: 270)
Posted On: 06/27/2017 6:08:16 PM
Post# of 72443
Ouch! Innate Immunotherapeutics stock plummets 92% after midstage clinical trial miss
http://www.marketwatch.com/story/innate-immun...-27-991256
Good thing IPIX isn't a one-trick pony. That company has congressman Chris Collins as the biggest shareholder and a board of director. Looks like "big names" don't always guarantee success.
http://www.marketwatch.com/story/innate-immun...-27-991256
Good thing IPIX isn't a one-trick pony. That company has congressman Chris Collins as the biggest shareholder and a board of director. Looks like "big names" don't always guarantee success.
(1)
(0)
Scroll down for more posts ▼
